ShareValue.ai

ShareValue scores for EPIGRAL.NSE: Valuation 62, Quality 66, Growth 43, Health 51.

EPIGRAL.NSE
NSE

Epigral Ltd.

₹1,106.20(-2.07%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

7% to 16%
Valuation
62
Fair Value
Price vs Value
Quality
66
Moderate
Business Strength
Growth
43
Moderate
Revenue & Earnings
Health
51
Moderate
Financial Stability
Momentum
33
Bearish
Price Trend

Company Details

About

Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins and compounds, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and detergents, fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and polytetrafluoroethylene (PTFE) pipes. The company was formerly known as Meghmani Finechem Limited and changed its name to Epigral Limited in August 2023. Epigral Limited was incorporated in 2007 and is based in Ahmedabad, India.

Score Analysis

AI Investment Thesis

Data as of:Jun 29, 2026
|
Last calculated:Jun 29, 2026